Rank | Gene Set | Z-score |
---|---|---|
1 | daunorubicin metabolic process (GO:0044597) | 8.11971896 |
2 | polyketide metabolic process (GO:0030638) | 8.11971896 |
3 | doxorubicin metabolic process (GO:0044598) | 8.11971896 |
4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.25022029 |
5 | primary alcohol catabolic process (GO:0034310) | 5.24003383 |
6 | * cellular glucuronidation (GO:0052695) | 5.21332201 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.12591024 |
8 | L-phenylalanine catabolic process (GO:0006559) | 5.12591024 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.01759059 |
10 | L-phenylalanine metabolic process (GO:0006558) | 5.01759059 |
11 | * glucuronate metabolic process (GO:0019585) | 4.96022557 |
12 | * uronic acid metabolic process (GO:0006063) | 4.96022557 |
13 | sulfur amino acid catabolic process (GO:0000098) | 4.87757544 |
14 | aromatic amino acid family catabolic process (GO:0009074) | 4.82081153 |
15 | negative regulation of fibrinolysis (GO:0051918) | 4.68417043 |
16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.64583000 |
17 | indole-containing compound catabolic process (GO:0042436) | 4.57136855 |
18 | indolalkylamine catabolic process (GO:0046218) | 4.57136855 |
19 | tryptophan catabolic process (GO:0006569) | 4.57136855 |
20 | cysteine metabolic process (GO:0006534) | 4.52431082 |
21 | kynurenine metabolic process (GO:0070189) | 4.36980733 |
22 | bile acid biosynthetic process (GO:0006699) | 4.35751864 |
23 | protein carboxylation (GO:0018214) | 4.35722616 |
24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.35722616 |
25 | regulation of fibrinolysis (GO:0051917) | 4.33446183 |
26 | glyoxylate metabolic process (GO:0046487) | 4.32655709 |
27 | homocysteine metabolic process (GO:0050667) | 4.28917927 |
28 | regulation of plasminogen activation (GO:0010755) | 4.27840313 |
29 | tryptophan metabolic process (GO:0006568) | 4.26328952 |
30 | urea cycle (GO:0000050) | 4.17438716 |
31 | urea metabolic process (GO:0019627) | 4.17438716 |
32 | regulation of protein activation cascade (GO:2000257) | 4.13081566 |
33 | complement activation, alternative pathway (GO:0006957) | 4.08782512 |
34 | epoxygenase P450 pathway (GO:0019373) | 4.07847765 |
35 | xenobiotic catabolic process (GO:0042178) | 4.06174401 |
36 | COPII vesicle coating (GO:0048208) | 4.01662999 |
37 | alpha-linolenic acid metabolic process (GO:0036109) | 4.01315112 |
38 | response to nitrosative stress (GO:0051409) | 4.00231782 |
39 | glycoside metabolic process (GO:0016137) | 3.99365134 |
40 | high-density lipoprotein particle remodeling (GO:0034375) | 3.95884183 |
41 | regulation of complement activation (GO:0030449) | 3.94288952 |
42 | bile acid metabolic process (GO:0008206) | 3.83484716 |
43 | bile acid and bile salt transport (GO:0015721) | 3.77501076 |
44 | nitrogen cycle metabolic process (GO:0071941) | 3.76026308 |
45 | flavonoid metabolic process (GO:0009812) | 3.74320021 |
46 | fibrinolysis (GO:0042730) | 3.73749206 |
47 | triglyceride homeostasis (GO:0070328) | 3.72615735 |
48 | acylglycerol homeostasis (GO:0055090) | 3.72615735 |
49 | drug catabolic process (GO:0042737) | 3.72530258 |
50 | regulation of cholesterol homeostasis (GO:2000188) | 3.69415021 |
51 | intestinal cholesterol absorption (GO:0030299) | 3.68696721 |
52 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.67474519 |
53 | * nucleotide-sugar biosynthetic process (GO:0009226) | 3.66345294 |
54 | benzene-containing compound metabolic process (GO:0042537) | 3.65743695 |
55 | lysine catabolic process (GO:0006554) | 3.64987508 |
56 | lysine metabolic process (GO:0006553) | 3.64987508 |
57 | regulation of triglyceride catabolic process (GO:0010896) | 3.64422468 |
58 | retinal metabolic process (GO:0042574) | 3.60302147 |
59 | aldehyde catabolic process (GO:0046185) | 3.60115353 |
60 | amino-acid betaine metabolic process (GO:0006577) | 3.58128654 |
61 | positive regulation of extracellular matrix organization (GO:1903055) | 3.56424653 |
62 | progesterone metabolic process (GO:0042448) | 3.56377065 |
63 | intestinal absorption (GO:0050892) | 3.54852230 |
64 | negative regulation of sterol transport (GO:0032372) | 3.53445344 |
65 | negative regulation of cholesterol transport (GO:0032375) | 3.53445344 |
66 | Golgi transport vesicle coating (GO:0048200) | 3.52179616 |
67 | COPI coating of Golgi vesicle (GO:0048205) | 3.52179616 |
68 | reverse cholesterol transport (GO:0043691) | 3.51897068 |
69 | regulation of cholesterol esterification (GO:0010872) | 3.45590644 |
70 | serine family amino acid catabolic process (GO:0009071) | 3.45255386 |
71 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.42801654 |
72 | aromatic amino acid family metabolic process (GO:0009072) | 3.40606656 |
73 | plasma lipoprotein particle remodeling (GO:0034369) | 3.38801927 |
74 | protein-lipid complex remodeling (GO:0034368) | 3.38801927 |
75 | macromolecular complex remodeling (GO:0034367) | 3.38801927 |
76 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.38440345 |
77 | phospholipid efflux (GO:0033700) | 3.37955646 |
78 | plasma lipoprotein particle clearance (GO:0034381) | 3.37622863 |
79 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.35924092 |
80 | protein retention in ER lumen (GO:0006621) | 3.34562498 |
81 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.31856129 |
82 | lipoprotein metabolic process (GO:0042157) | 3.27537182 |
83 | collagen fibril organization (GO:0030199) | 3.25507550 |
84 | ethanol oxidation (GO:0006069) | 3.24612373 |
85 | quinone metabolic process (GO:1901661) | 3.24117307 |
86 | exogenous drug catabolic process (GO:0042738) | 3.23598749 |
87 | plasma lipoprotein particle assembly (GO:0034377) | 3.20276658 |
88 | serine family amino acid metabolic process (GO:0009069) | 3.18770775 |
89 | serine family amino acid biosynthetic process (GO:0009070) | 3.18395871 |
90 | regulation of bile acid biosynthetic process (GO:0070857) | 3.18055024 |
91 | cholesterol efflux (GO:0033344) | 3.17192601 |
92 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.17129966 |
93 | cellular modified amino acid catabolic process (GO:0042219) | 3.17059685 |
94 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.15339667 |
95 | protein hydroxylation (GO:0018126) | 3.14588673 |
96 | tyrosine metabolic process (GO:0006570) | 3.13936158 |
97 | alpha-amino acid catabolic process (GO:1901606) | 3.12998766 |
98 | peptidyl-proline hydroxylation (GO:0019511) | 3.12668221 |
99 | indolalkylamine metabolic process (GO:0006586) | 3.09375120 |
100 | amine catabolic process (GO:0009310) | 3.08119723 |
101 | cellular biogenic amine catabolic process (GO:0042402) | 3.08119723 |
102 | cholesterol homeostasis (GO:0042632) | 3.07674810 |
103 | sterol homeostasis (GO:0055092) | 3.05573401 |
104 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.05452628 |
105 | positive regulation of lipid catabolic process (GO:0050996) | 3.04976994 |
106 | cell adhesion mediated by integrin (GO:0033627) | 3.04970738 |
107 | protein-lipid complex assembly (GO:0065005) | 3.02553494 |
108 | glycine metabolic process (GO:0006544) | 3.01842452 |
109 | glutamate metabolic process (GO:0006536) | 3.00702669 |
110 | coenzyme catabolic process (GO:0009109) | 2.99956309 |
111 | drug transmembrane transport (GO:0006855) | 2.99848125 |
112 | negative regulation of protein activation cascade (GO:2000258) | 2.99046264 |
113 | cellular amino acid catabolic process (GO:0009063) | 2.98228724 |
114 | keratan sulfate catabolic process (GO:0042340) | 2.93034471 |
115 | negative regulation of lipase activity (GO:0060192) | 2.92949113 |
116 | cellular aldehyde metabolic process (GO:0006081) | 2.91321032 |
117 | C21-steroid hormone metabolic process (GO:0008207) | 2.88039339 |
118 | arginine metabolic process (GO:0006525) | 2.87469465 |
119 | drug metabolic process (GO:0017144) | 2.87113473 |
120 | opsonization (GO:0008228) | 2.87101503 |
121 | chondrocyte proliferation (GO:0035988) | 2.86885909 |
122 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.86564295 |
123 | phospholipid homeostasis (GO:0055091) | 2.84818126 |
124 | digestion (GO:0007586) | 2.79844903 |
125 | omega-hydroxylase P450 pathway (GO:0097267) | 2.69789097 |
126 | ribosome assembly (GO:0042255) | 2.62918452 |
127 | L-serine metabolic process (GO:0006563) | 2.60305276 |
128 | cobalamin metabolic process (GO:0009235) | 2.59608877 |
129 | negative regulation of coagulation (GO:0050819) | 2.57564571 |
130 | desmosome organization (GO:0002934) | 2.56603559 |
131 | primary alcohol metabolic process (GO:0034308) | 2.56000707 |
132 | anterior/posterior axis specification, embryo (GO:0008595) | 2.55606735 |
133 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.52925423 |
134 | 4-hydroxyproline metabolic process (GO:0019471) | 2.51855686 |
135 | negative regulation of wound healing (GO:0061045) | 2.50742301 |
136 | ethanol metabolic process (GO:0006067) | 2.50490255 |
137 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.48462073 |
138 | negative regulation of complement activation (GO:0045916) | 2.42681154 |
139 | negative regulation of hemostasis (GO:1900047) | 2.41519837 |
140 | negative regulation of blood coagulation (GO:0030195) | 2.41519837 |
141 | retinoid metabolic process (GO:0001523) | 2.39740275 |
142 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.35491603 |
143 | diterpenoid metabolic process (GO:0016101) | 2.35364985 |
144 | ER overload response (GO:0006983) | 2.34249290 |
145 | cyclooxygenase pathway (GO:0019371) | 2.32597487 |
146 | terpenoid metabolic process (GO:0006721) | 2.31851308 |
147 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.31437921 |
148 | transcytosis (GO:0045056) | 2.30441522 |
149 | skin morphogenesis (GO:0043589) | 2.29766787 |
150 | lung vasculature development (GO:0060426) | 2.29261436 |
151 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.27476856 |
152 | gap junction assembly (GO:0016264) | 2.25438579 |
153 | cholesterol biosynthetic process (GO:0006695) | 2.24809496 |
154 | regulation of metalloenzyme activity (GO:0048552) | 2.22869385 |
155 | * nucleotide-sugar metabolic process (GO:0009225) | 2.22801472 |
156 | regulation of apoptotic cell clearance (GO:2000425) | 2.22754511 |
157 | acute-phase response (GO:0006953) | 2.22412387 |
158 | phenylpropanoid metabolic process (GO:0009698) | 2.21261905 |
159 | L-ascorbic acid metabolic process (GO:0019852) | 2.18860299 |
160 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.18334915 |
161 | Leydig cell differentiation (GO:0033327) | 2.18060081 |
162 | vesicle coating (GO:0006901) | 2.17807139 |
163 | paraxial mesoderm development (GO:0048339) | 2.17773230 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.58665448 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.17468399 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.34143728 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.93521559 |
5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.74037616 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.73678903 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.37142768 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.83793824 |
9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.51749818 |
10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.51215865 |
11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.39559145 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.20174120 |
13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.18458920 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.89639684 |
15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.58739400 |
16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.33083265 |
17 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.25712816 |
18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.13905009 |
19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13298105 |
20 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.09757606 |
21 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.97101902 |
22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.79957690 |
23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72791154 |
24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72059020 |
25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.71039410 |
26 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.70075678 |
27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.69014959 |
28 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.69013676 |
29 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.66174175 |
30 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.64844769 |
31 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.64844769 |
32 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.63707878 |
33 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63139231 |
34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.61952175 |
35 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.61197619 |
36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60246914 |
37 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.58348404 |
38 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.55711715 |
39 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55687616 |
40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53316237 |
41 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.49877322 |
42 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.49418006 |
43 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.46492062 |
44 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44635735 |
45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43945779 |
46 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.41308416 |
47 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.41277699 |
48 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.40552353 |
49 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.36569625 |
50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.36429368 |
51 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.34183698 |
52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34131841 |
53 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.33770762 |
54 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.33770762 |
55 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.32968525 |
56 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.32952841 |
57 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30264045 |
58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29574614 |
59 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.29278558 |
60 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28949057 |
61 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28818911 |
62 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26574894 |
63 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25868164 |
64 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25290406 |
65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.22955351 |
66 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22313945 |
67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20820842 |
68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19060628 |
69 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.18670191 |
70 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17961103 |
71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17759538 |
72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17235556 |
73 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16952116 |
74 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16246757 |
75 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.14839958 |
76 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14378501 |
77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13547777 |
78 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12338747 |
79 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.11199689 |
80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09283094 |
81 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.09180667 |
82 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08069345 |
83 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06637994 |
84 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06544111 |
85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06132597 |
86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05865031 |
87 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04354435 |
88 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.03960458 |
89 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03636630 |
90 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02161447 |
91 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00437333 |
92 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.00384153 |
93 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99637670 |
94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99008351 |
95 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.98813155 |
96 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97783936 |
97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95913309 |
98 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95734287 |
99 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.95093126 |
100 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93666491 |
101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92997608 |
102 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.92532747 |
103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91666813 |
104 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.91225835 |
105 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.90954485 |
106 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90862804 |
107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90503366 |
108 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.90190803 |
109 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89690525 |
110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88939686 |
111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86544468 |
112 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.86195780 |
113 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85728082 |
114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83884521 |
115 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83485310 |
116 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82173476 |
117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81574045 |
118 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.76755062 |
119 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.76312713 |
120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76024849 |
121 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.75438714 |
122 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.74280675 |
123 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.73793363 |
124 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.72378249 |
125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.71529601 |
126 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70515338 |
127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.67884755 |
128 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.67720601 |
129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67535081 |
130 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.67390289 |
131 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.63386988 |
132 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.63180427 |
133 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.61803081 |
134 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.61579710 |
135 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.61185877 |
136 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.60407933 |
137 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.59003259 |
138 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58782732 |
139 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.56928275 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 6.00192391 |
2 | MP0002139_abnormal_hepatobiliary_system | 5.85906868 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.50069168 |
4 | MP0005365_abnormal_bile_salt | 4.25541558 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.89191979 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.50145558 |
7 | MP0003252_abnormal_bile_duct | 3.39462186 |
8 | MP0003705_abnormal_hypodermis_morpholog | 3.35097992 |
9 | MP0008438_abnormal_cutaneous_collagen | 3.34363008 |
10 | MP0005503_abnormal_tendon_morphology | 2.77233305 |
11 | MP0003950_abnormal_plasma_membrane | 2.74547371 |
12 | MP0010329_abnormal_lipoprotein_level | 2.40451373 |
13 | MP0005275_abnormal_skin_tensile | 2.35059425 |
14 | MP0001666_abnormal_nutrient_absorption | 2.32657420 |
15 | MP0009384_cardiac_valve_regurgitation | 2.30385027 |
16 | MP0003195_calcinosis | 2.28652495 |
17 | MP0009840_abnormal_foam_cell | 2.08311144 |
18 | MP0005332_abnormal_amino_acid | 1.91679488 |
19 | MP0005083_abnormal_biliary_tract | 1.67607043 |
20 | MP0004019_abnormal_vitamin_homeostasis | 1.62876869 |
21 | MP0003279_aneurysm | 1.62600695 |
22 | MP0002282_abnormal_trachea_morphology | 1.61564425 |
23 | MP0002933_joint_inflammation | 1.57843114 |
24 | MP0005023_abnormal_wound_healing | 1.49334758 |
25 | MP0009053_abnormal_anal_canal | 1.46038400 |
26 | MP0009697_abnormal_copulation | 1.45158652 |
27 | MP0000609_abnormal_liver_physiology | 1.45070261 |
28 | MP0005623_abnormal_meninges_morphology | 1.43956818 |
29 | MP0010030_abnormal_orbit_morphology | 1.42497792 |
30 | MP0001958_emphysema | 1.39029115 |
31 | MP0000163_abnormal_cartilage_morphology | 1.38298632 |
32 | MP0003937_abnormal_limbs/digits/tail_de | 1.38194156 |
33 | MP0002060_abnormal_skin_morphology | 1.35198829 |
34 | MP0005319_abnormal_enzyme/_coenzyme | 1.34946860 |
35 | MP0004134_abnormal_chest_morphology | 1.30343877 |
36 | MP0009250_abnormal_appendicular_skeleto | 1.29335572 |
37 | MP0003186_abnormal_redox_activity | 1.29155749 |
38 | MP0010352_gastrointestinal_tract_polyps | 1.28800511 |
39 | MP0010368_abnormal_lymphatic_system | 1.28680209 |
40 | MP0003868_abnormal_feces_composition | 1.27190068 |
41 | MP0008004_abnormal_stomach_pH | 1.26173312 |
42 | MP0003890_abnormal_embryonic-extraembry | 1.24841350 |
43 | MP0002118_abnormal_lipid_homeostasis | 1.22603868 |
44 | MP0002138_abnormal_hepatobiliary_system | 1.20904338 |
45 | MP0002896_abnormal_bone_mineralization | 1.19390381 |
46 | MP0004957_abnormal_blastocyst_morpholog | 1.18718684 |
47 | MP0003566_abnormal_cell_adhesion | 1.18581284 |
48 | MP0002938_white_spotting | 1.15733877 |
49 | MP0010386_abnormal_urinary_bladder | 1.15361756 |
50 | MP0005508_abnormal_skeleton_morphology | 1.11955761 |
51 | MP0002115_abnormal_skeleton_extremities | 1.11868027 |
52 | MP0001299_abnormal_eye_distance/ | 1.08865017 |
53 | MP0006054_spinal_hemorrhage | 1.07989055 |
54 | MP0003191_abnormal_cellular_cholesterol | 1.07668971 |
55 | MP0008932_abnormal_embryonic_tissue | 1.05436224 |
56 | MP0010678_abnormal_skin_adnexa | 1.04060399 |
57 | MP0009643_abnormal_urine_homeostasis | 1.02865628 |
58 | MP0001243_abnormal_dermal_layer | 1.02839568 |
59 | MP0001542_abnormal_bone_strength | 1.01751784 |
60 | MP0001533_abnormal_skeleton_physiology | 0.99763211 |
61 | MP0004272_abnormal_basement_membrane | 0.99137458 |
62 | MP0003693_abnormal_embryo_hatching | 0.96148569 |
63 | MP0005390_skeleton_phenotype | 0.95743411 |
64 | MP0002877_abnormal_melanocyte_morpholog | 0.90848290 |
65 | MP0000462_abnormal_digestive_system | 0.90827487 |
66 | MP0000598_abnormal_liver_morphology | 0.89639336 |
67 | MP0002697_abnormal_eye_size | 0.89457294 |
68 | MP0000537_abnormal_urethra_morphology | 0.88523983 |
69 | MP0003942_abnormal_urinary_system | 0.88127356 |
70 | MP0005257_abnormal_intraocular_pressure | 0.87711852 |
71 | MP0000627_abnormal_mammary_gland | 0.87503111 |
72 | MP0003283_abnormal_digestive_organ | 0.87421031 |
73 | MP0002113_abnormal_skeleton_development | 0.86422109 |
74 | MP0005084_abnormal_gallbladder_morpholo | 0.86242014 |
75 | MP0001764_abnormal_homeostasis | 0.84672622 |
76 | MP0001661_extended_life_span | 0.84137773 |
77 | MP0001915_intracranial_hemorrhage | 0.82729733 |
78 | MP0005220_abnormal_exocrine_pancreas | 0.80878085 |
79 | MP0004233_abnormal_muscle_weight | 0.80568179 |
80 | MP0003436_decreased_susceptibility_to | 0.79991650 |
81 | MP0001286_abnormal_eye_development | 0.79828679 |
82 | MP0008007_abnormal_cellular_replicative | 0.79445145 |
83 | MP0005197_abnormal_uvea_morphology | 0.79096555 |
84 | MP0003300_gastrointestinal_ulcer | 0.78458595 |
85 | MP0000613_abnormal_salivary_gland | 0.78272189 |
86 | MP0003091_abnormal_cell_migration | 0.77975630 |
87 | MP0000467_abnormal_esophagus_morphology | 0.77819895 |
88 | MP0000538_abnormal_urinary_bladder | 0.77812673 |
89 | MP0002089_abnormal_postnatal_growth/wei | 0.77708740 |
90 | MP0003011_delayed_dark_adaptation | 0.77583279 |
91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77166791 |
92 | MP0005248_abnormal_Harderian_gland | 0.75641577 |
93 | * MP0002084_abnormal_developmental_patter | 0.73538826 |
94 | MP0003122_maternal_imprinting | 0.73148770 |
95 | MP0000534_abnormal_ureter_morphology | 0.72783901 |
96 | MP0010234_abnormal_vibrissa_follicle | 0.72556830 |
97 | MP0005164_abnormal_response_to | 0.72476718 |
98 | MP0003941_abnormal_skin_development | 0.71677088 |
99 | MP0003656_abnormal_erythrocyte_physiolo | 0.71211477 |
100 | MP0003795_abnormal_bone_structure | 0.70703822 |
101 | MP0000013_abnormal_adipose_tissue | 0.70233000 |
102 | MP0000762_abnormal_tongue_morphology | 0.70081185 |
103 | MP0009764_decreased_sensitivity_to | 0.69712941 |
104 | MP0002295_abnormal_pulmonary_circulatio | 0.69558417 |
105 | MP0002168_other_aberrant_phenotype | 0.69332108 |
106 | MP0002796_impaired_skin_barrier | 0.68638942 |
107 | MP0005408_hypopigmentation | 0.67784115 |
108 | MP0003943_abnormal_hepatobiliary_system | 0.66900101 |
109 | MP0001881_abnormal_mammary_gland | 0.66231547 |
110 | MP0000432_abnormal_head_morphology | 0.66088970 |
111 | MP0009763_increased_sensitivity_to | 0.65743524 |
112 | MP0001697_abnormal_embryo_size | 0.65529305 |
113 | * MP0001672_abnormal_embryogenesis/_devel | 0.65066740 |
114 | * MP0005380_embryogenesis_phenotype | 0.65066740 |
115 | * MP0001730_embryonic_growth_arrest | 0.64287319 |
116 | MP0001293_anophthalmia | 0.64185706 |
117 | * MP0002085_abnormal_embryonic_tissue | 0.63475428 |
118 | MP0004264_abnormal_extraembryonic_tissu | 0.62700339 |
119 | MP0003936_abnormal_reproductive_system | 0.62290915 |
120 | MP0005376_homeostasis/metabolism_phenot | 0.61376494 |
121 | MP0009780_abnormal_chondrocyte_physiolo | 0.61028283 |
122 | MP0002136_abnormal_kidney_physiology | 0.59518884 |
123 | MP0005395_other_phenotype | 0.58950151 |
124 | MP0002249_abnormal_larynx_morphology | 0.58011803 |
125 | MP0002254_reproductive_system_inflammat | 0.57918402 |
126 | MP0000767_abnormal_smooth_muscle | 0.57736356 |
127 | MP0002233_abnormal_nose_morphology | 0.57418717 |
128 | MP0005166_decreased_susceptibility_to | 0.55999041 |
129 | MP0005636_abnormal_mineral_homeostasis | 0.55477075 |
130 | MP0002998_abnormal_bone_remodeling | 0.55173984 |
131 | MP0001756_abnormal_urination | 0.54202476 |
132 | MP0001270_distended_abdomen | 0.53944235 |
133 | MP0003453_abnormal_keratinocyte_physiol | 0.53857623 |
134 | MP0008469_abnormal_protein_level | 0.53026913 |
135 | MP0001663_abnormal_digestive_system | 0.53009084 |
136 | MP0002108_abnormal_muscle_morphology | 0.52818300 |
137 | MP0002111_abnormal_tail_morphology | 0.52050304 |
138 | MP0002109_abnormal_limb_morphology | 0.50943108 |
139 | MP0009642_abnormal_blood_homeostasis | 0.50191877 |
140 | MP0005381_digestive/alimentary_phenotyp | 0.49209157 |
141 | MP0003755_abnormal_palate_morphology | 0.48548959 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Epiphyseal dysplasia (HP:0002656) | 4.71796346 |
2 | Cupped ribs (HP:0000887) | 4.67885176 |
3 | Abnormal tarsal ossification (HP:0008369) | 4.63791569 |
4 | Intrahepatic cholestasis (HP:0001406) | 4.51470261 |
5 | Vitreoretinal degeneration (HP:0000655) | 4.30944669 |
6 | Deep venous thrombosis (HP:0002625) | 4.29257875 |
7 | Xanthomatosis (HP:0000991) | 4.14124386 |
8 | Irregular epiphyses (HP:0010582) | 4.14070222 |
9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.06782978 |
10 | Hypobetalipoproteinemia (HP:0003563) | 4.05350688 |
11 | Flat acetabular roof (HP:0003180) | 3.96785469 |
12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.73049964 |
13 | Protrusio acetabuli (HP:0003179) | 3.64104900 |
14 | Abnormal foot bone ossification (HP:0010675) | 3.63065099 |
15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.58246773 |
16 | Neonatal short-limb short stature (HP:0008921) | 3.45976410 |
17 | Premature rupture of membranes (HP:0001788) | 3.41603138 |
18 | Hypoplastic ischia (HP:0003175) | 3.29927874 |
19 | Hypolipoproteinemia (HP:0010981) | 3.25606863 |
20 | Prolonged partial thromboplastin time (HP:0003645) | 3.19013236 |
21 | Cervical subluxation (HP:0003308) | 3.05033019 |
22 | Delayed epiphyseal ossification (HP:0002663) | 3.00388403 |
23 | Complement deficiency (HP:0004431) | 3.00277995 |
24 | Abnormality of the ischium (HP:0003174) | 2.99344448 |
25 | Reduced antithrombin III activity (HP:0001976) | 2.98200009 |
26 | Flat capital femoral epiphysis (HP:0003370) | 2.93936272 |
27 | Fat malabsorption (HP:0002630) | 2.92012585 |
28 | Abnormal cartilage morphology (HP:0002763) | 2.90778339 |
29 | Hypoalphalipoproteinemia (HP:0003233) | 2.90335191 |
30 | Abnormality of carpal bone ossification (HP:0006257) | 2.87120926 |
31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.80472689 |
32 | Metaphyseal cupping (HP:0003021) | 2.79139789 |
33 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.76427101 |
34 | Small epiphyses (HP:0010585) | 2.76175117 |
35 | Arterial tortuosity (HP:0005116) | 2.75368721 |
36 | Osteoarthritis (HP:0002758) | 2.75351078 |
37 | Tetraparesis (HP:0002273) | 2.74770904 |
38 | Myocardial infarction (HP:0001658) | 2.73693558 |
39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.73231240 |
40 | Protuberant abdomen (HP:0001538) | 2.68969660 |
41 | Abnormality of complement system (HP:0005339) | 2.65303303 |
42 | Epidermoid cyst (HP:0200040) | 2.65195034 |
43 | Vascular tortuosity (HP:0004948) | 2.62727305 |
44 | Microglossia (HP:0000171) | 2.57830586 |
45 | Coxa vara (HP:0002812) | 2.57465126 |
46 | Arthropathy (HP:0003040) | 2.57311536 |
47 | Conjugated hyperbilirubinemia (HP:0002908) | 2.56997066 |
48 | Genu varum (HP:0002970) | 2.56769351 |
49 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.55782186 |
50 | Beaking of vertebral bodies (HP:0004568) | 2.54453632 |
51 | Hydroxyprolinuria (HP:0003080) | 2.54159995 |
52 | Abnormality of proline metabolism (HP:0010907) | 2.54159995 |
53 | Hyperlipoproteinemia (HP:0010980) | 2.50409438 |
54 | Abnormal delivery (HP:0001787) | 2.50154191 |
55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.48874532 |
56 | Cardiovascular calcification (HP:0011915) | 2.43866260 |
57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.42025251 |
58 | Hyperammonemia (HP:0001987) | 2.37140444 |
59 | Abnormality of dentin (HP:0010299) | 2.33835060 |
60 | Metaphyseal irregularity (HP:0003025) | 2.32544585 |
61 | Abnormal ossification of hand bones (HP:0005921) | 2.31807674 |
62 | Flattened epiphyses (HP:0003071) | 2.29552432 |
63 | Platyspondyly (HP:0000926) | 2.29240922 |
64 | Spontaneous abortion (HP:0005268) | 2.28881357 |
65 | Glomerulonephritis (HP:0000099) | 2.27849981 |
66 | Peritonitis (HP:0002586) | 2.26985639 |
67 | Vascular calcification (HP:0004934) | 2.26876864 |
68 | Joint hemorrhage (HP:0005261) | 2.23158749 |
69 | Soft skin (HP:0000977) | 2.21020963 |
70 | Abnormality of the acetabulum (HP:0003170) | 2.20486738 |
71 | Abnormality of methionine metabolism (HP:0010901) | 2.19659858 |
72 | Stillbirth (HP:0003826) | 2.18381340 |
73 | Thoracolumbar scoliosis (HP:0002944) | 2.18114987 |
74 | Hypercholesterolemia (HP:0003124) | 2.17556526 |
75 | Ectopia lentis (HP:0001083) | 2.17509576 |
76 | Ovoid vertebral bodies (HP:0003300) | 2.17317786 |
77 | Abnormal hand bone ossification (HP:0010660) | 2.16536496 |
78 | Abnormality of the vertebral endplates (HP:0005106) | 2.16401337 |
79 | Vertebral clefting (HP:0008428) | 2.13576882 |
80 | Hyperglycinuria (HP:0003108) | 2.11481328 |
81 | Abnormality of glycolysis (HP:0004366) | 2.11042271 |
82 | Aortic aneurysm (HP:0004942) | 2.09920655 |
83 | Hypoglycemic coma (HP:0001325) | 2.09682386 |
84 | Steatorrhea (HP:0002570) | 2.08205776 |
85 | Abnormal vertebral ossification (HP:0100569) | 2.07169322 |
86 | Biconcave vertebral bodies (HP:0004586) | 2.05485816 |
87 | Aortic dissection (HP:0002647) | 2.05108986 |
88 | Hepatocellular carcinoma (HP:0001402) | 2.04742254 |
89 | Irregular vertebral endplates (HP:0003301) | 2.02767295 |
90 | Vertebral compression fractures (HP:0002953) | 2.02712179 |
91 | Hyperglycinemia (HP:0002154) | 2.01918225 |
92 | Enlarged epiphyses (HP:0010580) | 2.01638967 |
93 | Malnutrition (HP:0004395) | 2.01563935 |
94 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.01466819 |
95 | Abdominal distention (HP:0003270) | 2.01120503 |
96 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.00912538 |
97 | Abnormality of glycine metabolism (HP:0010895) | 2.00912538 |
98 | Bifid tongue (HP:0010297) | 1.99461733 |
99 | Mild short stature (HP:0003502) | 1.98911605 |
100 | Ileus (HP:0002595) | 1.98788531 |
101 | Increased serum pyruvate (HP:0003542) | 1.98700842 |
102 | Blue sclerae (HP:0000592) | 1.95425328 |
103 | Follicular hyperkeratosis (HP:0007502) | 1.95194074 |
104 | Right ventricular cardiomyopathy (HP:0011663) | 1.95187321 |
105 | Asymmetry of the thorax (HP:0001555) | 1.95011220 |
106 | Spinal cord compression (HP:0002176) | 1.94973840 |
107 | Skin nodule (HP:0200036) | 1.94573878 |
108 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.93813669 |
109 | Osteolytic defects of the hand bones (HP:0009699) | 1.93813669 |
110 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.93531686 |
111 | Abnormality of femoral epiphyses (HP:0006499) | 1.93531686 |
112 | Pterygium (HP:0001059) | 1.93433637 |
113 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.93380217 |
114 | Mesomelia (HP:0003027) | 1.93200848 |
115 | Abnormality of the lumbar spine (HP:0100712) | 1.91709402 |
116 | Proximal tubulopathy (HP:0000114) | 1.89360924 |
117 | Ulnar bowing (HP:0003031) | 1.87927098 |
118 | Ketosis (HP:0001946) | 1.87341660 |
119 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.86544380 |
120 | Abnormality of nucleobase metabolism (HP:0010932) | 1.83835361 |
121 | Mitral stenosis (HP:0001718) | 1.83466552 |
122 | Sex reversal (HP:0012245) | 1.80445422 |
123 | Abnormal sex determination (HP:0012244) | 1.80445422 |
124 | Renal duplication (HP:0000075) | 1.78119494 |
125 | Abnormality of the nasal septum (HP:0000419) | 1.77524475 |
126 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.75300381 |
127 | Ankle contracture (HP:0006466) | 1.74736295 |
128 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.73788814 |
129 | Abnormal protein glycosylation (HP:0012346) | 1.73788814 |
130 | Abnormal glycosylation (HP:0012345) | 1.73788814 |
131 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.73788814 |
132 | Back pain (HP:0003418) | 1.73421838 |
133 | Short nail (HP:0001799) | 1.71788602 |
134 | Type I transferrin isoform profile (HP:0003642) | 1.70201792 |
135 | Hypophosphatemic rickets (HP:0004912) | 1.59154609 |
136 | Abnormality of the umbilical cord (HP:0010881) | 1.58888999 |
137 | Focal segmental glomerulosclerosis (HP:0000097) | 1.57879057 |
138 | Glomerulosclerosis (HP:0000096) | 1.54497201 |
139 | Wormian bones (HP:0002645) | 1.54225926 |
140 | Rickets (HP:0002748) | 1.52254230 |
141 | Short humerus (HP:0005792) | 1.52018961 |
142 | Abnormality of vitamin metabolism (HP:0100508) | 1.51498746 |
143 | Exocrine pancreatic insufficiency (HP:0001738) | 1.51104587 |
144 | Spondylolisthesis (HP:0003302) | 1.50972618 |
145 | Nephritis (HP:0000123) | 1.50325759 |
146 | Stenosis of the external auditory canal (HP:0000402) | 1.50291128 |
147 | Fibular aplasia (HP:0002990) | 1.46391318 |
148 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.46160789 |
149 | Coronal craniosynostosis (HP:0004440) | 1.43333233 |
150 | Abnormality of serum amino acid levels (HP:0003112) | 1.42887940 |
151 | Hypothermia (HP:0002045) | 1.42696984 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DDR2 | 4.15383063 |
2 | MAP3K3 | 3.67340915 |
3 | ERN1 | 3.29439863 |
4 | STK38L | 3.24402376 |
5 | EIF2AK3 | 3.19403677 |
6 | LATS1 | 2.85204527 |
7 | FRK | 2.80537468 |
8 | SIK1 | 2.80316394 |
9 | EIF2AK1 | 2.60463136 |
10 | MST1R | 2.46762094 |
11 | TRIB3 | 2.46709389 |
12 | EPHA2 | 2.35513795 |
13 | MAP3K12 | 2.33587451 |
14 | ERBB4 | 2.33449927 |
15 | BCKDK | 2.23733689 |
16 | NUAK1 | 2.08056614 |
17 | TRIM28 | 2.05408320 |
18 | NEK1 | 2.02802548 |
19 | PRKG2 | 2.00286801 |
20 | TESK1 | 1.99673986 |
21 | PKN2 | 1.94252278 |
22 | BCR | 1.92998908 |
23 | PTK6 | 1.75486445 |
24 | FGFR4 | 1.75390847 |
25 | NEK9 | 1.72017534 |
26 | MST4 | 1.65251997 |
27 | PDGFRA | 1.61851726 |
28 | TTN | 1.56720477 |
29 | PBK | 1.56008560 |
30 | SCYL2 | 1.55979208 |
31 | EPHB2 | 1.46458971 |
32 | SRPK1 | 1.46389737 |
33 | MET | 1.42698548 |
34 | PIK3CG | 1.42696513 |
35 | TTK | 1.42366423 |
36 | RIPK1 | 1.42030551 |
37 | STK39 | 1.41511472 |
38 | TSSK6 | 1.40118335 |
39 | STK3 | 1.37701369 |
40 | PTK2 | 1.34621194 |
41 | LATS2 | 1.29272596 |
42 | ERBB3 | 1.28714961 |
43 | PLK3 | 1.28363893 |
44 | PIM2 | 1.27263071 |
45 | TRPM7 | 1.26621774 |
46 | BUB1 | 1.25907840 |
47 | PIK3CA | 1.24768530 |
48 | RPS6KA4 | 1.20878272 |
49 | STK24 | 1.16840605 |
50 | FER | 1.16587703 |
51 | TAOK2 | 1.13940034 |
52 | STK10 | 1.11690123 |
53 | EPHA3 | 1.10943897 |
54 | CDK8 | 1.10884812 |
55 | LIMK1 | 1.08402783 |
56 | MAP2K1 | 1.08323498 |
57 | CDK6 | 1.02901527 |
58 | MKNK1 | 1.02891020 |
59 | TAF1 | 1.00389668 |
60 | ACVR1B | 1.00131143 |
61 | PAK2 | 0.99340506 |
62 | VRK2 | 0.97886129 |
63 | FLT3 | 0.96880652 |
64 | GRK1 | 0.93811675 |
65 | MKNK2 | 0.92507165 |
66 | MAP2K3 | 0.91724074 |
67 | MAP3K10 | 0.91639130 |
68 | BRSK1 | 0.91181566 |
69 | ERBB2 | 0.91088259 |
70 | TGFBR2 | 0.89417793 |
71 | LRRK2 | 0.88591516 |
72 | AKT3 | 0.86769895 |
73 | PAK3 | 0.86093411 |
74 | ABL2 | 0.85709980 |
75 | MELK | 0.83303014 |
76 | BMX | 0.82290322 |
77 | PAK4 | 0.81893272 |
78 | NME1 | 0.79393267 |
79 | WEE1 | 0.78907419 |
80 | MAP2K2 | 0.77413918 |
81 | KDR | 0.76545386 |
82 | ROCK1 | 0.75828806 |
83 | PRKCE | 0.73952932 |
84 | MAP3K11 | 0.73210612 |
85 | MAPK11 | 0.72577299 |
86 | EIF2AK2 | 0.71576829 |
87 | TESK2 | 0.70596590 |
88 | BMPR1B | 0.70258156 |
89 | MYLK | 0.69147588 |
90 | MAP3K9 | 0.65891381 |
91 | GSK3A | 0.65710347 |
92 | MAP3K14 | 0.65132614 |
93 | IRAK3 | 0.64717670 |
94 | MAP4K2 | 0.64328182 |
95 | TBK1 | 0.64278942 |
96 | TAOK1 | 0.63575803 |
97 | NME2 | 0.62196501 |
98 | ILK | 0.60344781 |
99 | EPHB1 | 0.59932129 |
100 | DYRK1B | 0.59340084 |
101 | MAP3K2 | 0.58923714 |
102 | PRKAA2 | 0.58661183 |
103 | FGFR1 | 0.57604056 |
104 | PLK1 | 0.57081454 |
105 | CSK | 0.56958029 |
106 | WNK4 | 0.56922107 |
107 | PDGFRB | 0.56913652 |
108 | STK16 | 0.54562845 |
109 | NEK6 | 0.54416306 |
110 | MAP3K8 | 0.53896310 |
111 | INSRR | 0.52964855 |
112 | CDK7 | 0.52879158 |
113 | TAOK3 | 0.51652278 |
114 | MAP3K5 | 0.49658054 |
115 | MTOR | 0.49130463 |
116 | CDK9 | 0.48252012 |
117 | TYK2 | 0.47048932 |
118 | AURKB | 0.46841301 |
119 | MUSK | 0.45567622 |
120 | MAP3K7 | 0.45361965 |
121 | FGFR3 | 0.44807262 |
122 | MOS | 0.44759051 |
123 | ZAK | 0.44227972 |
124 | PLK2 | 0.42811070 |
125 | MAPKAPK3 | 0.40943381 |
126 | IGF1R | 0.40851449 |
127 | JAK1 | 0.39991654 |
128 | MAPK4 | 0.38560869 |
129 | PDK2 | 0.37112735 |
130 | WNK3 | 0.35645134 |
131 | SIK3 | 0.35024129 |
132 | CAMK2D | 0.34064137 |
133 | CSNK1E | 0.33845586 |
134 | TNIK | 0.33814229 |
135 | CHEK2 | 0.32732800 |
136 | BRSK2 | 0.31986052 |
137 | CHUK | 0.31983430 |
138 | DAPK1 | 0.31038889 |
139 | PRKCI | 0.31003453 |
140 | INSR | 0.30852586 |
141 | ABL1 | 0.30438731 |
142 | STK38 | 0.30405213 |
143 | RPS6KB2 | 0.27319435 |
144 | CSNK1G1 | 0.26077768 |
145 | MAPK15 | 0.24240309 |
146 | LMTK2 | 0.24163097 |
147 | PRKACG | 0.23065267 |
148 | JAK2 | 0.21041085 |
149 | SRC | 0.21037373 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.69250571 |
2 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.59530673 |
3 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.88558672 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.77770970 |
5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.59685900 |
6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.49677918 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42463289 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40769885 |
9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.39736892 |
10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.39491298 |
11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.37044986 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.26982550 |
13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.19415183 |
14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.19152490 |
15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.09023153 |
16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.06613485 |
17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.98649489 |
18 | Retinol metabolism_Homo sapiens_hsa00830 | 1.89573345 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.88524300 |
20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.86500400 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83392931 |
22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.81345203 |
23 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.77027478 |
24 | Protein export_Homo sapiens_hsa03060 | 1.75740274 |
25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74028250 |
26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.72904189 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72230168 |
28 | Peroxisome_Homo sapiens_hsa04146 | 1.69047531 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65709489 |
30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.51491338 |
31 | Proteasome_Homo sapiens_hsa03050 | 1.49702339 |
32 | Bile secretion_Homo sapiens_hsa04976 | 1.48907821 |
33 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.41827522 |
34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.40981539 |
35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39146402 |
36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.38284125 |
37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36801832 |
38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33582439 |
39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.33278015 |
40 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.33180006 |
41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30579866 |
42 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.28428264 |
43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28073550 |
44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24764616 |
45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24318319 |
46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23501023 |
47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15616369 |
48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11462824 |
49 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.10462289 |
50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09708258 |
51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06695836 |
52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.05967167 |
53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.05067408 |
54 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.04756013 |
55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03826461 |
56 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03134552 |
57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02134492 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01808470 |
59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01575957 |
60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99500855 |
61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98297832 |
62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98166995 |
63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92610390 |
64 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.86802449 |
65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86178215 |
66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86083644 |
67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.85631607 |
68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83998266 |
69 | ABC transporters_Homo sapiens_hsa02010 | 0.78238599 |
70 | Lysine degradation_Homo sapiens_hsa00310 | 0.76747631 |
71 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73909176 |
72 | Tight junction_Homo sapiens_hsa04530 | 0.68951664 |
73 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.64117760 |
74 | Mineral absorption_Homo sapiens_hsa04978 | 0.63415628 |
75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.58910886 |
76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55705092 |
77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55094505 |
78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50120897 |
79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49925077 |
80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48635500 |
81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48044003 |
82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47129440 |
83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46602041 |
84 | Bladder cancer_Homo sapiens_hsa05219 | 0.46574127 |
85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45386736 |
86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42109176 |
87 | Focal adhesion_Homo sapiens_hsa04510 | 0.41941904 |
88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37596769 |
89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37221911 |
90 | RNA transport_Homo sapiens_hsa03013 | 0.36550911 |
91 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.35342799 |
92 | Malaria_Homo sapiens_hsa05144 | 0.35014168 |
93 | RNA polymerase_Homo sapiens_hsa03020 | 0.33917079 |
94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.33694859 |
95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32685407 |
96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.29437637 |
97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.29284428 |
98 | Insulin resistance_Homo sapiens_hsa04931 | 0.27483171 |
99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27189382 |
100 | Adherens junction_Homo sapiens_hsa04520 | 0.26427659 |
101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.25843927 |
102 | Amoebiasis_Homo sapiens_hsa05146 | 0.23620767 |
103 | Prion diseases_Homo sapiens_hsa05020 | 0.22024423 |
104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15018793 |
105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.13264281 |
106 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.09785395 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08782613 |
108 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.08746789 |
109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08663915 |
110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.07817493 |
111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.07564619 |
112 | Legionellosis_Homo sapiens_hsa05134 | 0.06256955 |
113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.06015092 |
114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.05737788 |
115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04596730 |
116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03930404 |
117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.03692826 |
118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.01740234 |